PRINCETON, NJ, Dec. 4 - While the pharmaceutical industry may agree that genomic technology will impact the drug discovery process, the jury is still out on what that impact may be, according to panelists at the Economist 's Pharmaceuticals 2001 conference, held December 3-4 in Princeton, NJ.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.